Table of Contents Author Guidelines Submit a Manuscript
Cholesterol
Volume 2015, Article ID 292935, 5 pages
http://dx.doi.org/10.1155/2015/292935
Research Article

The Effect of Elevated Triglycerides on the Onset and Progression of Coronary Artery Disease: A Retrospective Chart Review

1Broward Health Medical Center, 1600 South Andrews Avenue, Fort Lauderdale, FL 33316, USA
2Health Professions Division’s Statistical Consulting Center, Nova Southeastern University, 3200 South University Drive, Davie, FL 33328, USA
3United Memorial Medical Center, 127 North Street, Batavia, NY 14020, USA

Received 19 September 2015; Revised 13 October 2015; Accepted 20 October 2015

Academic Editor: Gerhard M. Kostner

Copyright © 2015 Deepu Daniel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Stone, J. Robinson, A. H. Lichtenstein et al., “2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines,” Circulation, vol. 129, pp. S1–S45, 2014. View at Publisher · View at Google Scholar
  2. Z. Reiner, Catapano A. L, G. De Backer et al., “ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS),” European Heart Journal, vol. 32, no. 14, pp. 1769–1818, 2011. View at Publisher · View at Google Scholar
  3. J. Perk, G. De Backer, H. Gohlke et al., “European guidelines on cardiovascular disease prevention in clinical practice,” European Heart Journal, vol. 33, no. 13, pp. 1635–1701, 2012. View at Publisher · View at Google Scholar
  4. J. C. LaRosa, S. M. Grundy, D. D. Waters et al., “Intensive lipid lowering with atorvastatin in patients with stable coronary disease,” The New England Journal of Medicine, vol. 352, no. 14, pp. 1425–1435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. T. R. Pedersen, O. Faergeman, J. J. P. Kastelein et al., “High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial,” Journal of the American Medical Association, vol. 294, no. 19, pp. 2437–2445, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. H. Eckel, J. M. Jakicic, J. D. Ard et al., “2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk,” Journal of the American College of Cardiology, vol. 63, no. 25, pp. 2960–2984, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Wolff, B. Starfield, and G. Anderson, “Prevalence, expenditures, and complications of multiple chronic conditions in the elderly,” Archives of Internal Medicine, vol. 162, no. 20, pp. 2269–2276, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. National Cholesterol Education Program, National Heart-Lung and Blood Institute, and National Institutes of Health, Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report, NIH Publication no. 02-5215, National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md, USA, 2002.
  9. Z. Lu, W. Kou, B. Du et al., “Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction,” The American Journal of Cardiology, vol. 101, no. 12, pp. 1689–1693, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. E. Rosenfeld, N. S. Wenger, and M. Kagawa-Singer, “End-of-life decision making: a qualitative study of elderly individuals,” Journal of General Internal Medicine, vol. 15, no. 9, pp. 620–625, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Glynn, W. Koenig, B. G. Nordestgaard, J. Shepherd, and P. M. Ridker, “Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial,” Annals of Internal Medicine, vol. 152, no. 8, pp. 488–496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Miller, N. J. Stone, C. Ballantyne et al., “Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association,” Circulation, vol. 123, no. 20, pp. 2292–2333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. The AIM-HIGH Investigators, “Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy,” The New England Journal of Medicine, vol. 365, no. 24, pp. 2255–2267, 2011. View at Publisher · View at Google Scholar
  14. M. J. Chapman, H. N. Ginsberg, P. Amarenco et al., “Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management,” European Heart Journal, vol. 32, no. 11, pp. 1345–1361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Ž. Reiner, “Are elevated serum triglycerides really a risk factor for coronary artery disease?” Cardiology, vol. 131, no. 4, pp. 225–227, 2015. View at Publisher · View at Google Scholar